Committed to eliminating viral infectious diseases
Led by antiviral experts and seasoned executives, our team is devoted to translating antiviral research breakthroughs into urgently needed medicines.
We Don’t Aim for One. We Aim for All.
We are driven by our “one drug, many bugs” vision that will lead to cures for a wide range of viral infections affecting billions of people worldwide.
Exploiting the Achilles Heel of Viral Infection.
TSG has developed a unique set of antiviral peptides that target medically important viruses with high potency and selectivity.
“The one-bug, one-drug approach is inadequate.”
Anthony Fauci
M.D., Director, National Institute of Allergy and Infectious Diseases